Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/Bff42981f8016f3c62ec23634878846e4> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- Bff42981f8016f3c62ec23634878846e4 NCIT_P378 "NCI" @default.
- Bff42981f8016f3c62ec23634878846e4 type Axiom @default.
- Bff42981f8016f3c62ec23634878846e4 annotatedProperty IAO_0000115 @default.
- Bff42981f8016f3c62ec23634878846e4 annotatedSource NCIT_C173043 @default.
- Bff42981f8016f3c62ec23634878846e4 annotatedTarget "The unique identifier assigned to the arm of the Molecular Analysis for Therapy Choice (MATCH) phase II clinical trial that is investigating treatment with ulixertinib in patients with tumors that have BRAF fusions or BRAF gene mutations, excluding those with BRAF V600E or V600K substitution mutations and central nervous system primary malignancy." @default.